Breathlessness (dyspnea) is a massive topic for the UKMLA AKT because it spans so many systems. When you're faced with a patient "short of puff," the goal is to quickly narrow down whether it's a cardiac, respiratory, or "other" issue.

I've put together a quick breakdown of the main differentials you'll need to keep in mind for your exams.

{
  "markdown": "| System | Acute Causes | Chronic Causes |\n| :--- | :--- | :--- |\n| **Cardiac** | Acute Heart Failure (Pulmonary Edema), ACS, Arrhythmia | Chronic Heart Failure, Valvular Heart Disease |\n| **Respiratory** | Asthma exacerbation, COPD exacerbation, PE, Pneumonia, Pneumothorax | COPD, Asthma, Interstitial Lung Disease (ILD), Bronchiectasis, Lung Cancer |\n| **Other** | Anxiety/Hyperventilation, Anaphylaxis, Diabetic Ketoacidosis (DKA) | Anemia, Obesity, Deconditioning, Hyperthyroidism |",
  "title": "Differential Diagnosis of Breathlessness",
  "thinking_message": "Organizing the differentials for breathlessness...",
  "contentType": "table"
}

The BNP Approach (NICE Guidelines)

B-type Natriuretic Peptide (BNP) or NT-proBNP is your best friend for ruling out heart failure. It's released when the ventricles are stretched.

• High Negative Predictive Value: If the BNP is low, it's very unlikely to be heart failure.
• NICE Thresholds (NT-proBNP):
  • < 400 pg/mL: Heart failure is unlikely.
  • 400 - 2000 pg/mL: Refer for specialist assessment and echocardiogram within 6 weeks.
  • > 2000 pg/mL: Urgent referral for specialist assessment and echo within 2 weeks.
• Note: BNP can be falsely elevated in AF, age, and renal failure, or falsely low in patients taking certain medications (like ACEi/ARBs) or those with a high BMI.

Spirometry: Obstructive vs. Restrictive

Spirometry is the gold standard for differentiating airway diseases. The key value is the FEV1/FVC ratio.

{
  "markdown": "| Pattern | FEV1/FVC Ratio | Common Causes |\n| :--- | :--- | :--- |\n| **Obstructive** | **< 0.7 (or < Lower Limit of Normal)** | Asthma, COPD, Bronchiectasis |\n| **Restrictive** | **> 0.7 (Normal or High)** | Pulmonary Fibrosis (ILD), Obesity, Kyphoscoliosis, Neuromuscular weakness |\n| **Mixed** | < 0.7 | Can occur in severe COPD or combined COPD/Fibrosis |",
  "title": "Spirometry Interpretation Table",
  "thinking_message": "Breaking down the spirometry patterns...",
  "contentType": "table"
}

• Reversibility: In asthma, you expect an improvement in FEV1 of >12% and >200ml after a bronchodilator. COPD typically shows minimal reversibility.

Chest X-Ray (CXR) Approach

The CXR is often the first-line investigation. For the AKT, you need to recognize the "classic" signs of the big hitters.

• Heart Failure (ABCDE mnemonic):
  • A: Alveolar edema (Bat's wing opacities)
  • B: Kerley B lines (interstitial edema)
  • C: Cardiomegaly (Cardiothoracic ratio > 0.5)
  • D: Dilated upper lobe vessels
  • E: Effusions (Pleural)
• Pneumothorax: Look for a visible lung edge and an absence of lung markings peripheral to it.
• Pneumonia: Look for consolidation (patchy or lobar) with air bronchograms.

Let me find a good visual aid to help you spot these heart failure signs on a CXR.

[tool call: default_api:search_assets{query:chest X-ray showing heart failure signs cardiomegaly kerley b lines bat wing opacities,thinking_message:Searching for a high-yield CXR image...,title:Heart Failure CXR Signs}]

After you've mastered the basics, it's worth diving into the specific management for each of these conditions. I'll pull up some relevant lessons for you to explore further.

[tool call: default_api:get_related_lessons_by_search_query{description:management of heart failure, COPD, and asthma for UKMLA AKT,thinking_message:Finding the best lessons for your revision...,title:Breathlessness Management Lessons}]